|
|
Post by JHam on Jan 26, 2015 12:24:51 GMT
|
|
|
|
Post by JHam on Jan 26, 2015 13:25:22 GMT
Up handsomely in pre-market on this news. Although this is only pre-clinical, I had my doubts on NurOwn working in Autism, so this is surprisingly good news for me. Interesting that we haven't heard any pre-clinical data results from MS. With the quote from Fiorino about planning the next stage for Autism it makes you wonder if that will be the next indication they go after.
|
|
